Cygnus unveils new ELISA kit for gene therapy April 19, 2019 -- Cygnus Technologies has introduced a new enzyme-linked immunosorbent assay (ELISA) test for use with recombinant vaccines and viral vectors in gene therapy to detect endonuclease impurities.
LabCorp to exchange research units with Envigo April 19, 2019 -- LabCorp and Envigo have announced a deal in which LabCorp will buy Envigo's nonclinical contract research services business, while Envigo will absorb the U.S. research products business of LabCorp's Covance drug development unit.
Quest sells STD tests directly to consumers April 18, 2019 -- Quest Diagnostics has launched new test packages for sexually transmitted diseases (STDs) that will be sold directly to consumers as part of its QuestDirect program.
Beckman Coulter gets FDA nod for early sepsis test April 18, 2019 -- Beckman Coulter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Early Sepsis Indicator, a hematology-based cellular biomarker designed to assist emergency department physicians with the triage and diagnosis of sepsis.
Open-access software takes aim at ELISA test variability April 18, 2019 -- Researchers from Boston have developed open-source software called ELISAtools that is designed to reduce the variability in enzyme-linked immunosorbent assay (ELISA) tests used for research. They describe their work in an April 17 article in PLOS One.
USPSTF questions blood lead screening in children, pregnant women April 17, 2019 -- Blood testing for elevated lead levels is accurate, but there is not enough evidence to support the screening of asymptomatic pregnant women or asymptomatic children 5 years of age or younger, the U.S. Preventive Services Task Force (USPSTF) has concluded in a final recommendation statement. Discuss